Rila Therapeutics, a biotech company dedicated to combating chronic fibrotic diseases, has announced the dosing of the first group of subjects in a phase 1 trial of RLA-23174 in China, in collaboration with Yingli Pharmaceutical

Arrowhead Pharmaceuticals, Inc. has announced new interim clinical findings on ARO-RAGE, an RNAi-based therapy designed to treat inflammatory lung conditions such as asthma, during the American Thoracic Society

Drug Farm announced today that the U.S. Food and Drug Administration has given the green light to the Investigational New Drug application for DF-003. This oral alpha-kinase 1

Flamingo Therapeutics has initiated a new Investigator-initiated Trial aimed at assessing the safety and effectiveness of danvatirsen in patients with acute myeloid leukemia and myelodysplastic syndrome

Verrica Pharmaceuticals Inc., specializing in dermatology therapeutics, has announced a significant update to its licensing agreement with Torii Pharmaceutical Co. Ltd. This involves collaborating on a global pivotal Phase 3 clinical trial of YCANTH®

Petros Pharmaceuticals, Inc., a company focused on improving access to medication through over-the-counter drug development programs, has announced that all strengths of its prescription erectile dysfunction medication,

AriBio Co., Ltd., a biotechnology company dedicated to leading the treatment of neurodegenerative diseases, announced that the National Medical Products Administration of China, along with the Center for Drug Evaluation

Brii Biosciences Limited, a leading biotechnology company, announced today that the National Medical Products Administration's Center for Drug Evaluation has granted Breakthrough Therapy Designations

PharmaTher Holdings Ltd., a specialty pharmaceutical company, has received an Amendment Acknowledgment Letter from the U.S. Food and Drug Administration for its Priority Original Abbreviated New Drug Application

The Jackson Laboratory, a nonprofit biomedical research organization, has forged a strategic partnership with AbTherx, a biotechnology innovator, to advance antibody discovery and expedite the development of vital new therapies.